Geoffrey Martha Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 5 hours ago
Geoffrey Martha has an estimated net worth of at least $31.2 million*, as of Aug. 5, 2026. They own 327,866 shares of MDT stock. They have sold 30,613 shares of MDT stock since 2021, for an estimated $3.0 million.
Geoffrey Martha $MDT SEC Form 4 Insider Trading
Geoffrey Martha has filed a total of 3 insider trades in $MDT since 2021. Their most recent trade was a sale of 17,519 shares, made on Jun 07, 2024. Their largest trade was a sale of 17,519 shares, made on Jun 07, 2024. We estimate that they now own 327,866 shares of $MDT, worth an estimated $28.2 million.
Insider Trading at $MDT
There have been a total of 49 insider trades reported at $MDT since 2021, with 10,010 shares purchased and 332,345 shares sold. The most active insider traders in $MDT stock have been Harry Skip Kiil, Brett A. Wall, and Gregory L Smith. The most recent trade was a sale of 3,102 shares reported by Matthew R. Walter (SVP, Chief HR Officer), made on Jul 08, 2026.
History of Insider Stock Trades by Geoffrey Martha
$MDT Executives and Stock Owners with Insider Trades
-
Harry Skip Kiil, EVP & President Cardiovascular
-
Brett A. Wall, EVP & Pres Neuroscience
-
Gregory L Smith, EVP Global Ops & Supply Chain
-
Sean Salmon, EVP & President Cardiovascular
-
Hoedt Rob Ten, EVP and Pres. Global Regions
-
Karen L Parkhill, EVP & Chief Financial Officer
-
Bradley E Lerman, SVP General Counsel & Corp Sec
-
Geoffrey Martha, Chairman and CEO
-
Michael Marinaro, EVP & President, Surgical OU
-
Carol A Surface, SVP, Chief HR Officer
-
Geoffrey Martha, CEO
-
John R Liddicoat, EVP & President of Americas
-
Matthew R. Walter, SVP, Chief HR Officer
-
Robert John White, EVP & Pres. Medical Surgical
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.